SlideShare a Scribd company logo
Action Plan for Health Research  2009-13 Irish Heart Foundation  Collaborative Cardiovascular and Stroke Research Network  Inaugural Conference  Croke Park, Dublin  Friday 18th June 2010 Jim Breslin,  Department of Health & Children
Health Research Group Action Plan prepared by Health Research Group (HRG) HRG established in 2007 on foot of recommendation of  the Advisory Science Council -  Towards Better Health: Achieving a Step Change in Health Research in Ireland  Under the auspices of the Cabinet Committee on Science, Technology & Innovation &  Brings together all the key statutory stakeholders to deliver a joined up approach to health research issues.
Background to Action Plan ►  Broad acceptance of previous Health Research Strategies  ►   Major development in Health Service Structures ►   Development (& fragmentation) in health research environment ►   Health Service Transformation - quality & cost imperatives ► Excellence in Health Research a key competitive advantage  ►   Convincing case for ACTION
Building Ireland’s Smart Economy Contained a commitment to develop an  Action Plan for Health Research  in order to exploit opportunities for stronger linkages between our health sector, the health sciences and related FDI and indigenous sectors such as medical devices and biopharma.
Health Research: The Interconnections Quality health services, a vibrant health research system and social and economic prosperity are not separate but inextricably intertwined. High Performing Health Services Vibrant Health Research System Smart Economy
Two Key Issues Strong health research  system  needed to support: Transformation of health service delivery and patient outcomes Economic agenda in developing new products and services
Health Research Pathway Translation &  Application   - Clinical & patient  oriented research -Population Health Sciences -Health Services Research Basic Biomedical  Research Transformation  Health outcomes and system performance Commercialisation  New technologies
The Health Outcomes Gap EXISTING HEALTH OUTCOMES Potential Health Outcomes Alignment & Coordination of Treatments  and Services Implementation Gap Scientific Knowledge Gap
What will the Action Plan Achieve? Framework for co-ordination & accountability across diverse stakeholders. National priorities for health research. Enabling research infrastructure; in particular clinical research facilities in our main academic hospitals & scalable informatics and bio-banking solutions. More clinical trials networks, internationally linked.  Focus on commercialisation & industry partnerships.  Streamlined and predictable regulatory environment.
What will the Action Plan Achieve? 7. More clinicians & health care professionals doing high quality patient focused research. 8. Rebalancing activity towards patient related outcomes.  9. Increased capacity for population health and health services research.  10. Transformation of care pathways informed by (locally adapted) international research evidence.  11. Mechanisms to monitor and evaluate investment, across both health and economic dimensions.
Clinical Trials Action Plan recognises the benefits to patients of high quality patient-oriented clinical trials. Commits to establishing new clinical trials networks focusing on different areas Intended that such networks can share infrastructure and skills in areas such as informatics, biostatistics, etc Goal is to increase the volume and quality of clinical trials activity in the country for the benefit of patients and the economy.
Making It Happen Departments & Agencies represented on the Health Research Group have already begun implementing the actions in the areas of: Leadership & strategic direction Skills Infrastructure Bio-banking We have published the Action Plan in order to be accountable, to generate support and to tap into the enthusiasm and passion for research & innovation amongst diverse stakeholders.
THANK YOU

More Related Content

What's hot

East Midlands Academic Health Science Network – igniting innovation Dr Carl...
East Midlands Academic Health Science Network – igniting innovation   Dr Carl...East Midlands Academic Health Science Network – igniting innovation   Dr Carl...
East Midlands Academic Health Science Network – igniting innovation Dr Carl...
PM Society
 
Joint working the CRN perspective Professor Oleg Eremin
Joint working the CRN perspective   Professor Oleg EreminJoint working the CRN perspective   Professor Oleg Eremin
Joint working the CRN perspective Professor Oleg Eremin
PM Society
 
Fergal Lynch, Deputy Secretary General, Department of Health
Fergal Lynch, Deputy Secretary General, Department of HealthFergal Lynch, Deputy Secretary General, Department of Health
Fergal Lynch, Deputy Secretary General, Department of Health
Investnet
 
Joint Working workshop
Joint Working workshopJoint Working workshop
Joint Working workshop
PM Society
 
Benefits of engaging with the Specialised Services Commissioning Innovation Fund
Benefits of engaging with the Specialised Services Commissioning Innovation FundBenefits of engaging with the Specialised Services Commissioning Innovation Fund
Benefits of engaging with the Specialised Services Commissioning Innovation Fund
PM Society
 
A new tool for Clinical Commissioners, HWBs and everyone concerned with commi...
A new tool for Clinical Commissioners, HWBs and everyone concerned with commi...A new tool for Clinical Commissioners, HWBs and everyone concerned with commi...
A new tool for Clinical Commissioners, HWBs and everyone concerned with commi...
rightcare
 
Productivity in the health sector -- Peter Smith, United Kingdom
Productivity in the health sector -- Peter Smith, United KingdomProductivity in the health sector -- Peter Smith, United Kingdom
Productivity in the health sector -- Peter Smith, United Kingdom
OECD Governance
 
ECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
ECO 11: Medicines Optimisation in Northern Ireland - Frans van AndelECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
ECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
Innovation Agency
 
Dr. Graham Love, CEO, Health Research Board
Dr. Graham Love, CEO, Health Research BoardDr. Graham Love, CEO, Health Research Board
Dr. Graham Love, CEO, Health Research Board
Investnet
 
Developing national capacity for research and research ethics to improve deci...
Developing national capacity for research and research ethics to improve deci...Developing national capacity for research and research ethics to improve deci...
Developing national capacity for research and research ethics to improve deci...
WHO Regional Office for the Eastern Mediterranean
 
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 20142B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014
IKT-Norge
 
Joint working between the NHS and pharma
Joint working between the NHS and pharmaJoint working between the NHS and pharma
Joint working between the NHS and pharma
PM Society
 
James Downie
James DownieJames Downie
James Downie
Informa Australia
 
The vision for the Wessex AHSN
The vision for the Wessex AHSNThe vision for the Wessex AHSN
The vision for the Wessex AHSN
PM Society
 
Pharmacy working together to put Lord Carter’s recommendations into practice
Pharmacy working together to put Lord Carter’s recommendations into practicePharmacy working together to put Lord Carter’s recommendations into practice
Pharmacy working together to put Lord Carter’s recommendations into practice
Health and Care Innovation Expo
 
Diagnostic services atlas key headlines nov 2013 -v1
Diagnostic services  atlas   key headlines nov 2013 -v1Diagnostic services  atlas   key headlines nov 2013 -v1
Diagnostic services atlas key headlines nov 2013 -v1
rightcare
 
EuroBioForum 2013 - Day 2 | Rachael Ritchie
EuroBioForum 2013 - Day 2 | Rachael RitchieEuroBioForum 2013 - Day 2 | Rachael Ritchie
EuroBioForum 2013 - Day 2 | Rachael Ritchie
EuroBioForum
 
The vision, priorities & approach for ucl partners AHSN
The vision, priorities & approach for ucl partners AHSNThe vision, priorities & approach for ucl partners AHSN
The vision, priorities & approach for ucl partners AHSN
PM Society
 
Medicines optimisation: sharing best practices
Medicines optimisation: sharing best practicesMedicines optimisation: sharing best practices
Medicines optimisation: sharing best practices
AALForum
 
EuroBioForum 2013 - Day 1 | Pierre Meulien
EuroBioForum 2013 - Day 1 | Pierre MeulienEuroBioForum 2013 - Day 1 | Pierre Meulien
EuroBioForum 2013 - Day 1 | Pierre Meulien
EuroBioForum
 

What's hot (20)

East Midlands Academic Health Science Network – igniting innovation Dr Carl...
East Midlands Academic Health Science Network – igniting innovation   Dr Carl...East Midlands Academic Health Science Network – igniting innovation   Dr Carl...
East Midlands Academic Health Science Network – igniting innovation Dr Carl...
 
Joint working the CRN perspective Professor Oleg Eremin
Joint working the CRN perspective   Professor Oleg EreminJoint working the CRN perspective   Professor Oleg Eremin
Joint working the CRN perspective Professor Oleg Eremin
 
Fergal Lynch, Deputy Secretary General, Department of Health
Fergal Lynch, Deputy Secretary General, Department of HealthFergal Lynch, Deputy Secretary General, Department of Health
Fergal Lynch, Deputy Secretary General, Department of Health
 
Joint Working workshop
Joint Working workshopJoint Working workshop
Joint Working workshop
 
Benefits of engaging with the Specialised Services Commissioning Innovation Fund
Benefits of engaging with the Specialised Services Commissioning Innovation FundBenefits of engaging with the Specialised Services Commissioning Innovation Fund
Benefits of engaging with the Specialised Services Commissioning Innovation Fund
 
A new tool for Clinical Commissioners, HWBs and everyone concerned with commi...
A new tool for Clinical Commissioners, HWBs and everyone concerned with commi...A new tool for Clinical Commissioners, HWBs and everyone concerned with commi...
A new tool for Clinical Commissioners, HWBs and everyone concerned with commi...
 
Productivity in the health sector -- Peter Smith, United Kingdom
Productivity in the health sector -- Peter Smith, United KingdomProductivity in the health sector -- Peter Smith, United Kingdom
Productivity in the health sector -- Peter Smith, United Kingdom
 
ECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
ECO 11: Medicines Optimisation in Northern Ireland - Frans van AndelECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
ECO 11: Medicines Optimisation in Northern Ireland - Frans van Andel
 
Dr. Graham Love, CEO, Health Research Board
Dr. Graham Love, CEO, Health Research BoardDr. Graham Love, CEO, Health Research Board
Dr. Graham Love, CEO, Health Research Board
 
Developing national capacity for research and research ethics to improve deci...
Developing national capacity for research and research ethics to improve deci...Developing national capacity for research and research ethics to improve deci...
Developing national capacity for research and research ethics to improve deci...
 
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 20142B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014
 
Joint working between the NHS and pharma
Joint working between the NHS and pharmaJoint working between the NHS and pharma
Joint working between the NHS and pharma
 
James Downie
James DownieJames Downie
James Downie
 
The vision for the Wessex AHSN
The vision for the Wessex AHSNThe vision for the Wessex AHSN
The vision for the Wessex AHSN
 
Pharmacy working together to put Lord Carter’s recommendations into practice
Pharmacy working together to put Lord Carter’s recommendations into practicePharmacy working together to put Lord Carter’s recommendations into practice
Pharmacy working together to put Lord Carter’s recommendations into practice
 
Diagnostic services atlas key headlines nov 2013 -v1
Diagnostic services  atlas   key headlines nov 2013 -v1Diagnostic services  atlas   key headlines nov 2013 -v1
Diagnostic services atlas key headlines nov 2013 -v1
 
EuroBioForum 2013 - Day 2 | Rachael Ritchie
EuroBioForum 2013 - Day 2 | Rachael RitchieEuroBioForum 2013 - Day 2 | Rachael Ritchie
EuroBioForum 2013 - Day 2 | Rachael Ritchie
 
The vision, priorities & approach for ucl partners AHSN
The vision, priorities & approach for ucl partners AHSNThe vision, priorities & approach for ucl partners AHSN
The vision, priorities & approach for ucl partners AHSN
 
Medicines optimisation: sharing best practices
Medicines optimisation: sharing best practicesMedicines optimisation: sharing best practices
Medicines optimisation: sharing best practices
 
EuroBioForum 2013 - Day 1 | Pierre Meulien
EuroBioForum 2013 - Day 1 | Pierre MeulienEuroBioForum 2013 - Day 1 | Pierre Meulien
EuroBioForum 2013 - Day 1 | Pierre Meulien
 

Similar to Action Plan for Health Research

Enda connolly - HRB Strategic Business Plan 2010-2014 - 2009
Enda connolly - HRB Strategic Business Plan 2010-2014 - 2009Enda connolly - HRB Strategic Business Plan 2010-2014 - 2009
Enda connolly - HRB Strategic Business Plan 2010-2014 - 2009
ipposi
 
Stratified Medicines Innovation Platform
Stratified Medicines Innovation PlatformStratified Medicines Innovation Platform
Stratified Medicines Innovation Platform
EuroBioForum
 
ABPI big data road map
ABPI big data road mapABPI big data road map
ABPI big data road map
Hassan Chaudhury
 
Value based healthcare
Value based healthcareValue based healthcare
Value based healthcare
Asem Shadid
 
IHC Case Study Dec 2010
IHC Case Study Dec 2010IHC Case Study Dec 2010
IHC Case Study Dec 2010
Asset Based Finance and Leasing Ltd
 
Informing Healthier Choices Case Study
Informing Healthier Choices Case StudyInforming Healthier Choices Case Study
Informing Healthier Choices Case Study
Asset Based Finance and Leasing Ltd
 
Nwc academic health science network event slide deck
Nwc academic health science network event slide deckNwc academic health science network event slide deck
Nwc academic health science network event slide deck
3GDR
 
The role of clinical research in securing the future of the industry in Ireland
The role of clinical research in securing the future of the industry in IrelandThe role of clinical research in securing the future of the industry in Ireland
The role of clinical research in securing the future of the industry in Ireland
Irish Pharmaceutical Healthcare Association (IPHA)
 
HPAC0003 Strategic Plan June 2015 FINAL
HPAC0003 Strategic Plan June 2015 FINALHPAC0003 Strategic Plan June 2015 FINAL
HPAC0003 Strategic Plan June 2015 FINAL
Emma Hodgkin
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Professor G...
Let's Talk Research Annual Conference - 24th-25th September 2014 (Professor G...Let's Talk Research Annual Conference - 24th-25th September 2014 (Professor G...
Let's Talk Research Annual Conference - 24th-25th September 2014 (Professor G...
NHSNWRD
 
Ged byrne
Ged byrneGed byrne
Ged byrne
NHSNWRD
 
Dr Hamzah Baig
Dr Hamzah BaigDr Hamzah Baig
Dr Hamzah Baig
Doctors.net.uk
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017
ipposi
 
Case-study-NHS-East-Midlands
Case-study-NHS-East-MidlandsCase-study-NHS-East-Midlands
Case-study-NHS-East-Midlands
Jonny Sharp
 
Life Sciences
Life SciencesLife Sciences
Life Sciences
breslinj
 
Chapter 5: The future
Chapter 5: The futureChapter 5: The future
Global Dementia Legacy Event: Dr Shekhar Saxena
Global Dementia Legacy Event: Dr Shekhar SaxenaGlobal Dementia Legacy Event: Dr Shekhar Saxena
Global Dementia Legacy Event: Dr Shekhar Saxena
Department of Health
 
150408 Posters for Evidence Live
150408 Posters for Evidence Live150408 Posters for Evidence Live
150408 Posters for Evidence Live
Alison Turner
 
Registries for Medical Devices in Europe Reflection Paper_January 2016
Registries for Medical Devices in Europe Reflection Paper_January 2016Registries for Medical Devices in Europe Reflection Paper_January 2016
Registries for Medical Devices in Europe Reflection Paper_January 2016
Sebastian Gaiser
 
McDougall on Market Potential of Personalized Medicine
McDougall on Market Potential of Personalized Medicine McDougall on Market Potential of Personalized Medicine
McDougall on Market Potential of Personalized Medicine
The Ohio State University Wexner Medical Center
 

Similar to Action Plan for Health Research (20)

Enda connolly - HRB Strategic Business Plan 2010-2014 - 2009
Enda connolly - HRB Strategic Business Plan 2010-2014 - 2009Enda connolly - HRB Strategic Business Plan 2010-2014 - 2009
Enda connolly - HRB Strategic Business Plan 2010-2014 - 2009
 
Stratified Medicines Innovation Platform
Stratified Medicines Innovation PlatformStratified Medicines Innovation Platform
Stratified Medicines Innovation Platform
 
ABPI big data road map
ABPI big data road mapABPI big data road map
ABPI big data road map
 
Value based healthcare
Value based healthcareValue based healthcare
Value based healthcare
 
IHC Case Study Dec 2010
IHC Case Study Dec 2010IHC Case Study Dec 2010
IHC Case Study Dec 2010
 
Informing Healthier Choices Case Study
Informing Healthier Choices Case StudyInforming Healthier Choices Case Study
Informing Healthier Choices Case Study
 
Nwc academic health science network event slide deck
Nwc academic health science network event slide deckNwc academic health science network event slide deck
Nwc academic health science network event slide deck
 
The role of clinical research in securing the future of the industry in Ireland
The role of clinical research in securing the future of the industry in IrelandThe role of clinical research in securing the future of the industry in Ireland
The role of clinical research in securing the future of the industry in Ireland
 
HPAC0003 Strategic Plan June 2015 FINAL
HPAC0003 Strategic Plan June 2015 FINALHPAC0003 Strategic Plan June 2015 FINAL
HPAC0003 Strategic Plan June 2015 FINAL
 
Let's Talk Research Annual Conference - 24th-25th September 2014 (Professor G...
Let's Talk Research Annual Conference - 24th-25th September 2014 (Professor G...Let's Talk Research Annual Conference - 24th-25th September 2014 (Professor G...
Let's Talk Research Annual Conference - 24th-25th September 2014 (Professor G...
 
Ged byrne
Ged byrneGed byrne
Ged byrne
 
Dr Hamzah Baig
Dr Hamzah BaigDr Hamzah Baig
Dr Hamzah Baig
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017
 
Case-study-NHS-East-Midlands
Case-study-NHS-East-MidlandsCase-study-NHS-East-Midlands
Case-study-NHS-East-Midlands
 
Life Sciences
Life SciencesLife Sciences
Life Sciences
 
Chapter 5: The future
Chapter 5: The futureChapter 5: The future
Chapter 5: The future
 
Global Dementia Legacy Event: Dr Shekhar Saxena
Global Dementia Legacy Event: Dr Shekhar SaxenaGlobal Dementia Legacy Event: Dr Shekhar Saxena
Global Dementia Legacy Event: Dr Shekhar Saxena
 
150408 Posters for Evidence Live
150408 Posters for Evidence Live150408 Posters for Evidence Live
150408 Posters for Evidence Live
 
Registries for Medical Devices in Europe Reflection Paper_January 2016
Registries for Medical Devices in Europe Reflection Paper_January 2016Registries for Medical Devices in Europe Reflection Paper_January 2016
Registries for Medical Devices in Europe Reflection Paper_January 2016
 
McDougall on Market Potential of Personalized Medicine
McDougall on Market Potential of Personalized Medicine McDougall on Market Potential of Personalized Medicine
McDougall on Market Potential of Personalized Medicine
 

Action Plan for Health Research

  • 1. Action Plan for Health Research 2009-13 Irish Heart Foundation Collaborative Cardiovascular and Stroke Research Network Inaugural Conference Croke Park, Dublin Friday 18th June 2010 Jim Breslin, Department of Health & Children
  • 2. Health Research Group Action Plan prepared by Health Research Group (HRG) HRG established in 2007 on foot of recommendation of the Advisory Science Council - Towards Better Health: Achieving a Step Change in Health Research in Ireland Under the auspices of the Cabinet Committee on Science, Technology & Innovation & Brings together all the key statutory stakeholders to deliver a joined up approach to health research issues.
  • 3. Background to Action Plan ► Broad acceptance of previous Health Research Strategies ► Major development in Health Service Structures ► Development (& fragmentation) in health research environment ► Health Service Transformation - quality & cost imperatives ► Excellence in Health Research a key competitive advantage ► Convincing case for ACTION
  • 4. Building Ireland’s Smart Economy Contained a commitment to develop an Action Plan for Health Research in order to exploit opportunities for stronger linkages between our health sector, the health sciences and related FDI and indigenous sectors such as medical devices and biopharma.
  • 5. Health Research: The Interconnections Quality health services, a vibrant health research system and social and economic prosperity are not separate but inextricably intertwined. High Performing Health Services Vibrant Health Research System Smart Economy
  • 6. Two Key Issues Strong health research system needed to support: Transformation of health service delivery and patient outcomes Economic agenda in developing new products and services
  • 7. Health Research Pathway Translation & Application - Clinical & patient oriented research -Population Health Sciences -Health Services Research Basic Biomedical Research Transformation Health outcomes and system performance Commercialisation New technologies
  • 8. The Health Outcomes Gap EXISTING HEALTH OUTCOMES Potential Health Outcomes Alignment & Coordination of Treatments and Services Implementation Gap Scientific Knowledge Gap
  • 9. What will the Action Plan Achieve? Framework for co-ordination & accountability across diverse stakeholders. National priorities for health research. Enabling research infrastructure; in particular clinical research facilities in our main academic hospitals & scalable informatics and bio-banking solutions. More clinical trials networks, internationally linked. Focus on commercialisation & industry partnerships. Streamlined and predictable regulatory environment.
  • 10. What will the Action Plan Achieve? 7. More clinicians & health care professionals doing high quality patient focused research. 8. Rebalancing activity towards patient related outcomes. 9. Increased capacity for population health and health services research. 10. Transformation of care pathways informed by (locally adapted) international research evidence. 11. Mechanisms to monitor and evaluate investment, across both health and economic dimensions.
  • 11. Clinical Trials Action Plan recognises the benefits to patients of high quality patient-oriented clinical trials. Commits to establishing new clinical trials networks focusing on different areas Intended that such networks can share infrastructure and skills in areas such as informatics, biostatistics, etc Goal is to increase the volume and quality of clinical trials activity in the country for the benefit of patients and the economy.
  • 12. Making It Happen Departments & Agencies represented on the Health Research Group have already begun implementing the actions in the areas of: Leadership & strategic direction Skills Infrastructure Bio-banking We have published the Action Plan in order to be accountable, to generate support and to tap into the enthusiasm and passion for research & innovation amongst diverse stakeholders.